In current study, we constructed a novel prognostic model based on eight S100 family genes (S100A2-4, S100A8, S100A10-11, S100A16, and S100Z) and demonstrated its effectiveness in predicting the prognosis of gliomas (Figure 4 and Supplementary Figure 1). This evidence concerns the gene S100A16 and central nervous system cancer.